PMJ 2026 shows expanding photomask demand, Lasertec maintained at Buy
AI summary card
PMJ 2026 shows expanding photomask demand, Lasertec maintained at Buy
Goldman Sachs believes that the spread of EUV and growth in AI semiconductor demand are lifting the photomask market and actinic inspection demand, while customer validation of Lasertec's ACTIS and ecosystem partnerships provide a positive catalyst.
- AI semiconductors are seen as the main driver of EUV mask demand, with 2025-2030 sales CAGR of about 14%, well above non-AI semiconductors at about 2.6%.
- EUV masks have a shorter lifespan than conventional immersion lithography masks; in the survey, 74% of respondents said EUV mask life is less than 60% of that of immersion masks, implying more frequent replacement demand.
- Lasertec showed that ACTIS can capture phase defects that DUV cannot detect in principle, as well as defects on pellicle-equipped masks, and customer validation from Samsung, DNP and others reinforced the need for actinic inspection.
- Market consensus on High-NA EUV mass-production timing has shifted back to 2028 or later, but competition in mask writing equipment is intensifying, with NuFlare already shipping a High-NA EUV-compatible multi-beam mask writer.
Report interpretation
Overview
This report summarizes the key takeaways from Photomask Japan 2026, focusing on the photomask market, mask inspection equipment, and mask writing equipment. Goldman Sachs believes that the adoption of EUV lithography, stronger AI semiconductor demand, shorter EUV mask lifetimes, and rising adoption of actinic inspection together support expansion in the photomask and related inspection equipment markets, and it maintains a Buy rating on Lasertec.
Core views
The core view is: first, AI semiconductor demand is growing much faster than non-AI semiconductors and is becoming the main driver of expanding EUV mask demand; second, shorter EUV mask lifetimes drive more frequent replacement and inspection demand; third, actinic inspection is becoming increasingly important in next-generation nodes, and Lasertec's ACTIS is making progress in customer validation, defect-capture capability, and software ecosystem cooperation with Samsung; fourth, the timing of High-NA EUV mass production may be pushed out, but the competitive landscape for mask writing equipment remains worth monitoring.
Analysis framework
The report synthesizes demand-side, supply-side, customer adoption, technology validation, and competitive landscape information based on PMJ 2026 conference presentations and industry survey data. On the demand side, it focuses on AI semiconductors, new entrants to the EUV ecosystem, and mask replacement cycles; on the supply side, it focuses on independent mask shop mass-production systems, actinic inspection equipment, ACTIS customer validation, and the technology and customer progress of multi-beam mask writer vendors.
Methodology notes
Conference minutes and industry validation
Using disclosures from participants such as Tekscend Photomask, Lasertec, Samsung, DNP, IMS Nanofabrication, and NuFlare at Photomask Japan 2026 to assess industry trends in photomasks, inspection equipment, and writing equipment.
EUV mask lifetime and expected actinic inspection adoption
Cites survey results from the eBeam Initiative's 86-member survey to show that EUV masks have significantly shorter lifetimes than immersion masks, and that most respondents expect actinic inspection adoption for EUV masks to rise meaningfully over the next three years.
Growth, financial returns, valuation multiples, and composite percentile comparison
Goldman Sachs disclosed that its Factor Profile compares stocks with the market and peers using growth, financial returns, valuation multiples, and a composite indicator, but the body of this report does not provide Lasertec's specific factor scores.
M&A probability ranking
Goldman Sachs disclosed that its globally covered stocks can be assessed for potential acquisition probability on a scale of 1 to 3, but this framework is not a core basis for the investment view on Lasertec in this report.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Lasertec (6920.T)Core recommended name, maintained at Buy; ACTIS actinic mask inspection equipment is the report focus.
- Strengths
- ACTIS was shown to detect phase defects and through-pellicle defects that DUV cannot in principle capture; Samsung has adopted ACTIS and is co-developing AI defect filtering, automatic defect classification, and region analysis software with Lasertec; DNP validated that ACTIS A200 and A300 meet practical standards for A14 generation pattern resolution evaluation.
- Weaknesses
- The report does not provide a clear target price, upside, or financial forecast; the investment thesis depends on higher EUV mask inspection adoption and conversion of customer validation into mass-production demand.
- Comparison
- Compared with traditional DUV inspection, actinic EUV inspection is more necessary at next-generation nodes; relative to writer vendors, Lasertec is exposed to inspection infrastructure demand.
- Risks
- High-NA EUV mass-production timing could be pushed back, customer adoption could fall short of expectations, competing technologies or substitute inspection solutions could advance, and semiconductor capex cycles could fluctuate.
- JEOL (6951.T)A related covered company, rated Neutral; participates in multi-beam mask writing equipment through its partnership with IMS Nanofabrication.
- Strengths
- IMS/JEOL had previously been a leader in the multi-beam mask writer market and has patented technology that improves writing accuracy while maintaining throughput.
- Weaknesses
- Competitor NuFlare has recently gained share with the MBM-3000 and support ecosystem, and has already shipped the High-NA EUV-compatible MBM-4000.
- Comparison
- JEOL/IMS and NuFlare form the main competitive axis in multi-beam mask writing equipment.
- Risks
- Expansion of installations or usage at customers such as TSMC and SK Hynix by NuFlare could erode JEOL/IMS share.
- NuFlare TechnologyA mask writer competitor, included in the report as an industry competition reference.
- Strengths
- It shipped the first High-NA EUV-compatible multi-beam mask writer MBM-4000 in 2025 and completed customer acceptance; DSS and SO scan+TEC features show it can improve writing accuracy without sacrificing throughput.
- Weaknesses
- The report does not provide financial or rating information.
- Comparison
- Relative to IMS/JEOL, NuFlare has recently expanded market share thanks to a mature support system and an existing flagship model.
- Risks
- Delays in High-NA EUV mass production could affect the timing of demand realization for new equipment.
Key data
- Report date2026-04-13 11:48PM JSTCover information.
- AI semiconductor sales CAGRabout 14% (CY2025-30)Tekscend Photomask said AI semiconductor growth is about five times that of non-AI semiconductors, making it the main driver of EUV mask demand.
- Non-AI semiconductor sales CAGRabout 2.6% (CY2025-30)Used for comparison with AI semiconductor demand growth.
- EUV mask lifetime survey74% of respondents said EUV mask life is less than 60% of that of immersion masksFrom the eBeam Initiative's 2025 survey of 86 members.
- Tekscend mass-production system targetQ3 2026The independent mask shop is working to establish a mass-production system.
- High-NA EUV mass-production timing consensus2028 or laterThe report says market consensus has moved back from the prior survey point.
- Lasertec disclosed price¥41,230Listed in company-specific regulatory disclosures; no target price was extracted in the body.
- JEOL disclosed price¥6,208Listed in company-specific regulatory disclosures; JEOL is rated Neutral.
Impact & implications
In terms of investment implications, the expansion of EUV and AI semiconductor demand increases the importance of photomask inspection, and shorter EUV mask lifetimes may also lift inspection and replacement frequency. If Lasertec can continue to drive ACTIS adoption at major customers and combine inspection hardware with software for AI defect filtering, automatic classification, and region analysis, it may strengthen its position in next-generation mask inspection infrastructure. At the same time, delays in High-NA EUV mass production and changes in mask writer competition could affect the pace at which related equipment demand materializes and the valuation outlook for the sector.
Risks
- Consensus on full High-NA EUV mass production has shifted back to 2028 or later, which could delay demand for some next-generation equipment.
- If customer evaluations of ACTIS and actinic inspection do not convert into ongoing orders, the investment thesis for Lasertec could weaken.
- NuFlare's expanding share in multi-beam mask writing equipment could change expectations for competition along the related equipment chain.
- If semiconductor capex, AI semiconductor demand, or EUV ecosystem expansion falls short of expectations, photomask market growth could be affected.
- Goldman Sachs disclosed that it has an investment banking client relationship with Lasertec and may seek related compensation within the next three months; investors should watch for potential conflicts of interest disclosures.
What to watch
- Progress in ACTIS validation and mass-production adoption at customers such as Intel, TSMC, Samsung, and DNP.
- Whether actual adoption of EUV mask actinic inspection over the next three years rises materially, as industry surveys expect.
- The extent to which new entrants to the EUV ecosystem, such as Rapidus and Nanya, drive demand for independent mask shops and inspection equipment.
- The pace of independent mask shop buildout, including Tekscend's target mass-production system in Q3 2026.
- Whether the High-NA EUV production timeline continues to slip and how that affects order timing for inspection and writing equipment.
- Customer share changes among NuFlare's MBM-4000 and MBM-3000 versus IMS/JEOL multi-beam writers.